| Issue Date | Title | Author(s) |
| - | Pharmacological modulation of HIF-1 in the treatment of neuropsychiatric disorders | Sharma, D; Khan, H; Kumar, A; Grewal, AK; Dua, K; Singh, TG |
| 2023-10-13 | Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey. | Boyce, MJ; McCambridge, AB; Bradnam, LV; Canning, CG; De Oliveira, CQ; Verhagen, AP |
| 2023-03 | The relevance of rich club regions for functional outcome post-stroke is enhanced in women. | Bonkhoff, AK; Schirmer, MD; Bretzner, M; Hong, S; Regenhardt, RW; Donahue, KL; Nardin, MJ; Dalca, AV; Giese, A-K; Etherton, MR; Hancock, BL; Mocking, SJT; McIntosh, EC; Attia, J; Cole, JW; Donatti, A; Griessenauer, CJ; Heitsch, L; Holmegaard, L; Jood, K; Jimenez-Conde, J; Kittner, SJ; Lemmens, R; Levi, CR; McDonough, CW; Meschia, JF; Phuah, C-L; Ropele, S; Rosand, J; Roquer, J; Rundek, T; Sacco, RL; Schmidt, R; Sharma, P; Slowik, A; Sousa, A; Stanne, TM; Strbian, D; Tatlisumak, T; Thijs, V; Vagal, A; Wasselius, J; Woo, D; Zand, R; McArdle, PF; Worrall, BB; Jern, C; Lindgren, AG; Maguire, J; Wu, O; Rost, NS; MRI-GENIE and GISCOME Investigators and the International Stroke Genetics Consortium, |
| 2023-08 | Social support buffers young men's resilient coping to psychological distress. | Sharp, P; Oliffe, JL; Kealy, D; Rice, SM; Seidler, ZE; Ogrodniczuk, JS |
| 2023-10 | Incorporating Genetic Testing Into the Care of Patients With Amyotrophic Lateral Sclerosis/Frontotemporal Degeneration Spectrum Disorders. | Chambers, C; Lichten, L; Crook, A; Uhlmann, WR; Dratch, L |
| - | Targeting inflammatory signaling in obsessive compulsive disorder: a promising approach | Bhatt, S; Anitha, K; Chellappan, DK; Mukherjee, D; Shilpi, S; Suttee, A; Gupta, G; Singh, TG; Dua, K |
| 2023-03 | Prevalence and management of sleep disturbance in adults with primary brain tumours and their caregivers: a systematic review. | Martin, JA; Hart, NH; Bradford, N; Naumann, F; Pinkham, MB; Pinkham, EP; Holland, JJ |
| - | Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease | Kakoty, V; Sarathlal, KC; Kaur, P; Wadhwa, P; Vishwas, S; Khan, FR; Alhazmi, AYM; Almasoudi, HH; Gupta, G; Chellappan, DK; Paudel, KR; Kumar, D; Dua, K; Singh, SK |
| 2023-01-01 | Aphasia outcome measurement in clinical practice: An international survey | Tyler, C; Finch, E; Shrubsole, K; Ryan, B; Soroli, E; Martinez-Ferreiro, S; Wallace, SJ |
| 2023-06 | Prognostication in post-stroke aphasia: Perspectives of people with aphasia on receiving information about recovery. | Cheng, BBY; Ryan, BJ; Copland, DA; Wallace, SJ |
